Alyeska Investment Group
GNTA

Alyeska Investment Group’s Genenta Science GNTA Stock Holding History

Alyeska Investment Group’s Portfolio GNTA Stock Details GNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-219,838
Closed -$328K – 668
2025
Q4 		$328K Buy
+219,838
New +$518K ﹤0.01% 570

Other funds holding GNTA

ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alyeska Investment Group's GNTA Position: Q1 2026 in Review

Alyeska Investment Group sold out of Genenta Science (GNTA) in Q1 2026, closing a stake of 219,838 shares — an estimated $328K sold.

Alyeska Investment Group first reported a position in GNTA in Q4 2025 and held it in 1 quarter. The position peaked at $328K in Q4 2025. 11 funds tracked by Wall St. Rank hold GNTA as of Q1 2026.

  • Alyeska Investment Group reported no remaining Genenta Science position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 219,838 Genenta Science shares in Q1 2026, an estimated $328K.
  • Alyeska Investment Group first reported a position in Genenta Science in Q4 2025 and held it in 1 quarter.
  • Alyeska Investment Group's Genenta Science position peaked at $328K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Genenta Science as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.